Key statistics
On Tuesday, Biodesix Inc (BDSX:NMQ) closed at 12.78, -37.35% below its 52-week high of 20.40, set on Feb 19, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.53 |
|---|---|
| High | 12.79 |
| Low | 10.92 |
| Bid | 11.05 |
| Offer | 13.20 |
| Previous close | 11.45 |
| Average volume | 136.35k |
|---|---|
| Shares outstanding | 7.96m |
| Free float | 3.60m |
| P/E (TTM) | -- |
| Market cap | 91.09m USD |
| EPS (TTM) | -5.36 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
- Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
- Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
- Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
- Biodesix Announces Third Quarter 2025 Results and Highlights
- Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
- Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
- Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
- Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
- Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
- Biodesix Announces One-for-Twenty Reverse Stock Split
More ▼
